Akorn, Inc.
https://www.akorn.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Akorn, Inc.
Generic Drugs: ‘Competitive’ Exclusivity Benefited Few Sponsors But Is Increasingly Popular
The six months of additional exclusivity from US FDA’s CGT program appears to have kept some generic sponsors from the market, and didn’t even prompt others to enter quickly, but use of the competitive generic exclusivity program continues to grow.
Digital Health Roundup, July 2021: Exec Chat With DTA, Start-Ups Grab New Funds, Agency Nods
In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.
Market Intel: Expanding Applications And Improved Offerings To Drive Robotically Assisted Surgery Market
The global market for robotically assisted surgical devices will reach $11.5bn by 2025 as system improvements drive sales.
The Microbiome’s Time To Shine
In this installment of our VC Playbook series, In Vivo sits down with Isabelle de Cremoux, CEO of Seventure. The company has been a pioneer investor in the microbiome space, which Cremoux believes has now reached a turning point.
Company Information
- Industry
- Distributors
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
-
- Hi-Tech Pharmacal
- Oak Pharmaceuticals, Inc., VersaPharm